Date and Time

Monday, January 28, 2013, 5:00 PM to 7:30 PM

place

Kitano Hospital, 2nd Health Check-up Building, 2nd floor, Conference Room

Short Lecture

Chair: Dr. Hiroyuki Koshiyama, Director of the Diabetes and Endocrinology Center, Kitano Hospital

“New ultra long acting basal insulin, Tresiba®”
Global Chief Medical Officer, Novo Nordisk Inc, USA (ex. Professor, Harvard Medical School & Joslin Clinic)
Alan Moses, MD

*This is a closed lecture aimed at medical staff at Kitano Hospital. If you would like to participate,HerePlease contact us by email at